亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Lung sparing in MR-guided non-adaptive SBRT treatment of peripheral lung tumors

医学 核医学 肺癌 肺容积 放射治疗计划 放射治疗 放射科 磁共振成像 内科学
作者
Ho Young Lee,Grace Lee,D. Ferguson,Shu‐Hui Hsu,Yue-Houng Hu,Elizabeth Huynh,Atchar Sudhyadhom,Christopher L. Williams,D.N. Cagney,Kelly Fitzgerald,Benjamin H. Kann,David Kozono,Jonathan E. Leeman,Raymond H. Mak,Zhaohui Han
出处
期刊:Biomedical Physics & Engineering Express [IOP Publishing]
卷期号:10 (4): 045048-045048 被引量:1
标识
DOI:10.1088/2057-1976/ad567d
摘要

Abstract Objective. We aim to: (1) quantify the benefits of lung sparing using non-adaptive magnetic resonance guided stereotactic body radiotherapy (MRgSBRT) with advanced motion management for peripheral lung cancers compared to conventional x-ray guided SBRT (ConvSBRT); (2) establish a practical decision-making guidance metric to assist a clinician in selecting the appropriate treatment modality. Approach. Eleven patients with peripheral lung cancer who underwent breath-hold, gated MRgSBRT on an MR-guided linear accelerator (MR linac) were studied. Four-dimensional computed tomography (4DCT)-based retrospective planning using an internal target volume (ITV) was performed to simulate ConvSBRT, which were evaluated against the original MRgSBRT plans. Metrics analyzed included planning target volume (PTV) coverage, various lung metrics and the generalized equivalent unform dose (gEUD). A dosimetric predictor for achievable lung metrics was derived to assist future patient triage across modalities. Main results. PTV coverage was high (median V100% > 98%) and comparable for both modalities. MRgSBRT had significantly lower lung doses as measured by V20 (median 3.2% versus 4.2%), mean lung dose (median 3.3 Gy versus 3.8 Gy) and gEUD. Breath-hold, gated MRgSBRT resulted in an average reduction of 47% in PTV volume and an average increase of 19% in lung volume. Strong correlation existed between lung metrics and the ratio of PTV to lung volumes (R PTV/Lungs ) for both modalities, indicating that R PTV/Lungs may serve as a good predictor for achievable lung metrics without the need for pre-planning. A threshold value of R PTV/Lungs < 0.035 is suggested to achieve V20 < 10% using ConvSBRT. MRgSBRT should otherwise be considered if the threshold cannot be met. Significance. The benefits of lung sparing using MRgSBRT were quantified for peripheral lung tumors; R PTV/Lungs was found to be an effective predictor for achievable lung metrics across modalities. R PTV/Lungs can assist a clinician in selecting the appropriate modality without the need for labor-intensive pre-planning, which has significant practical benefit for a busy clinic.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
9秒前
9秒前
机智夜雪发布了新的文献求助10
11秒前
玛琳卡迪马完成签到,获得积分10
11秒前
13秒前
zmjjkk完成签到,获得积分10
14秒前
和谐凉面完成签到,获得积分10
14秒前
16秒前
25秒前
火星上的山柳完成签到,获得积分10
26秒前
SiboN完成签到,获得积分10
30秒前
eee完成签到 ,获得积分10
30秒前
31秒前
32秒前
科研通AI2S应助科研通管家采纳,获得10
34秒前
Orange应助科研通管家采纳,获得10
34秒前
35秒前
Vv完成签到,获得积分10
36秒前
喜乐完成签到 ,获得积分10
40秒前
43秒前
45秒前
共享精神应助Yini采纳,获得20
50秒前
1分钟前
1分钟前
苏苏苏发布了新的文献求助10
1分钟前
poieu发布了新的文献求助20
1分钟前
充电宝应助怕黑的海菡采纳,获得10
1分钟前
1分钟前
1分钟前
Fn完成签到 ,获得积分0
1分钟前
姚老表完成签到,获得积分10
1分钟前
poieu完成签到,获得积分10
1分钟前
1分钟前
yeah发布了新的文献求助10
2分钟前
2分钟前
2分钟前
2分钟前
金币盒完成签到 ,获得积分10
2分钟前
橘橘橘橘橘橘白完成签到,获得积分10
2分钟前
久久丫完成签到 ,获得积分10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
PowerCascade: A Synthetic Dataset for Cascading Failure Analysis in Power Systems 2000
The Composition and Relative Chronology of Dynasties 16 and 17 in Egypt 1500
Picture this! Including first nations fiction picture books in school library collections 1500
Signals, Systems, and Signal Processing 610
Unlocking Chemical Thinking: Reimagining Chemistry Teaching and Learning 555
Rheumatoid arthritis drugs market analysis North America, Europe, Asia, Rest of world (ROW)-US, UK, Germany, France, China-size and Forecast 2024-2028 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6366632
求助须知:如何正确求助?哪些是违规求助? 8180480
关于积分的说明 17246149
捐赠科研通 5421428
什么是DOI,文献DOI怎么找? 2868450
邀请新用户注册赠送积分活动 1845554
关于科研通互助平台的介绍 1693078